Loading…

The Phosphoprotein Op18/Stathmin is Differentially Expressed in Ovarian Cancer

Abstract To identify potential prognostic indicators of ovarian cancer and identify targets for therapeutic strategies, mRNA differential display was used to analyze gene expression differences in normal, benign, and cancerous ovarian tissue. One cDNA isolated by this technique, Op18/stathmin, is a...

Full description

Saved in:
Bibliographic Details
Published in:Cancer investigation 2000, Vol.18 (8), p.722-730
Main Authors: Price, Douglas K., Ball, Jennifer R., Bahrani-Mostafavi, Zahra, Vachris, Judith C., Kaufman, Jay S., Naumann, R. Wendel, Higgins, Robert V., Hall, James B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract To identify potential prognostic indicators of ovarian cancer and identify targets for therapeutic strategies, mRNA differential display was used to analyze gene expression differences in normal, benign, and cancerous ovarian tissue. One cDNA isolated by this technique, Op18/stathmin, is a highly conserved gene that is reported to have many different functions within a cell, including signal transduction, control of the cell cycle, and the regulation of microtubules. Quantitative Northern blot analysis of 12 malignant ovarian samples, 8 benign ovarian tumors, and 10 normal ovarian tissue samples demonstrated overexpresaion of Op18/stathmin mRNA in the malignant cancers. Immunohistochemistry showed an apparent overex-pression of Op18/stathmin protein level and an association with proliferating cells
ISSN:0735-7907
1532-4192
DOI:10.3109/07357900009012204